Global Gene Therapy Market By Vector Type (Viral Vector(Retroviral, Adeno-associated) and Non – Viral(Oligonucleotides) Vector), By Gene Type (Antigen, Receptor, Growth Factors, Cytokine), By Delivery Method (Ex-Vivo & In Vivo Therapy), By Disease Indication (Ophthalmology, Neurology, Hematology) and Duchenne Muscular Dystrophy), By Distribution Channel (Hospitals, Clinics), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023-2032
- Published date: March 2024
- Report ID: 22161
- Number of Pages: 241
- Format:
-
keyboard_arrow_up
-
-
- Novartis AG Company Profile
- Biogen
- Gilead Science, Inc.
- Spark Therapeutics, Inc.
- Amgen, Inc.
- Jazz Pharmaceuticals, Inc.
- GlaxoSmithKline plc.
- Spartea Therapeutics
- Sibiono Gene Tech Co, Ltd.
- Orchard Therapeutics
- Bluebird Bio, Inc.
- Sunway Biotech CO, Ltd.
- Applied Genetic Corporation
- Astellas Therapeutics
- Merck & CO, Inc.
- REGENXIBO Inc.
- Sangamo Therapeutics, Inc.
- Cipla Inc.
- Intellia Therapeutics, Inc.
- BioMarin Pharmaceuticals Inc.
- Other Key Players
Our Clients
- 22161
- March 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
